Randomized phase III trial comparing Daunorubicin and ara-C (DA) versus ara-C, Daunorubicin, and Etoposide (ADE) as induction chemotherapy in pediatric acute myeloid leukemia (InPOG-AML-16-01)

• Venkatraman Radhakrishnan,
• Sameer Bakhshi,
• Smita Kayal,
• Cherian Thampy,
• Ankit Batra,
• Praveen Kumar Shenoy,
• Hemanth Kumar,
• Shilpi Chaudhary,
• Swaminathan Rajaraman,
• Reema Bisht,
• Biswajit Dubashi,
• Trivadi S. Ganesan

Affiliations

Venkatraman Radhakrishnan

Presenting Author: Venkatraman Radhakrishnan, Cancer Institute (W.I.A); Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry

Sameer Bakhshi

Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry

Smita Kayal

Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry

Cherian Thampy

Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry

Ankit Batra

Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry

Praveen Kumar Shenoy

Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry

Hemanth Kumar

Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry

Shilpi Chaudhary

Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry

Swaminathan Rajaraman

Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry

Reema Bisht

Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry

Biswajit Dubashi

Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry

Trivadi S. Ganesan

Cancer Institute (W.I.A); AIIMS, New Delhi; JIPMER, Puducherry